ѻýҕl

<ѻýҕl class="page-title">Clinical Challenges

ASH: DLBCL

<ѻýҕl class="page-description">American Society of Hematology

More in ASH: DLBCL

Clinical Challenges: Test Your Knowledge on Recent Advances in DLBCL

A three-question quiz covering our series on diffuse large B-cell lymphoma

Dec 26, 2023
A blue and pink neon sign with the words QUIZ TIME
Clinical Challenges: Secondary CNS Relapse in Diffuse Large B-Cell Lymphoma

Questions remain on how best to diagnose and treat CNS involvement in high-risk groups

Dec 26, 2023
ASH over a photo of San Diego Convention Center.
Clinical Challenges: Using Pola-R-CHP for Diffuse Large B-Cell Lymphoma

Regimen is approved for frontline treatment, but when it represents the best choice is less clear

Dec 18, 2023
ASH over a photo of San Diego Convention Center.
Clinical Challenges: CAR-T or Bispecifics in Relapsed/Refractory DLBCL

Patient preference, ease of administration, AEs may all weigh into treatment decisions

Dec 13, 2023
ASH over a photo of San Diego Convention Center.